Embrave Tech Solutions Private Limited - Due diligence report

A 360° intelligence report on Clinicea: trust score, financial health, credit view, compliance, directors, growth and distress signals - gen…

2015-07-30 Mumbai, Maharashtra Active Unlisted Active Compliant
ET Embrave Tech Solutions Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Clinicea — 360° Intelligence Report

Generated from MCA filings & public records
70/100
Trust Score
Moderate

Clinicea is assessed as Moderate with a Trust Score of 70/100. Clinicea is an active private limited indian non-government company incorporated in 2015, operating in the Information Technology sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Embrave Tech Solutions Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
45/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 3 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ASHWIN MAHENDRA NANAVATI 01234567 Director 01/04/2018 6 yrs Approved
AMOL SATISH LOLGE 01234567 Director 01/04/2018 6 yrs Approved
VINAYANAND ANANDARAO ADAPA 01234567 Director 01/04/2018 6 yrs Approved
SANJAY KESHUBHAI MITALIYA 01234567 Director 01/04/2018 6 yrs Approved
  • 4 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2018 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 3 transfer(s)

Promoters hold a majority stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 45
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Latest year revenue grew 1.42.
Operating for 10+ years.
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 2.1x in a year.
Negative net worth.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence74/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 3 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment51/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 12 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
10 Jun 2017
Securities allotted
1112 Equity Shares Without Differential Rights - 17.00 Lakh raised
Director appointed
ASHWIN MAHENDRA NANAVATI (Additional Director)
Director appointed
AMOL SATISH LOLGE (Additional Director)
31 Mar 2017
Share transfer (FY 2017)
150.00000000 shares to rahul
Share transfer (FY 2017)
50.00000000 shares to rahul
11 Jan 2017
Director ceased
AMI SANJAY MITALIYA
29 Dec 2016
Director appointed
VINAYANAND ANANDARAO ADAPA (Director)
31 Mar 2016
Share transfer (FY 2016)
2500.00000000 shares to ANANDARAO VINAYANAND
30 Jul 2015
Incorporated
Registered with Roc Mumbai Ii
Director appointed
SANJAY KESHUBHAI MITALIYA (Director)
10

Key Observations

Auto-generated from the data above
Revenue grew 24% over the last 2 financial year(s).
Net profit margin moved from 0.86 to 61%.
Compliance record is strong - status, filings and flags are clean.
4 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a majority stake as per the FY 2018 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Arithme U72900JH2003PTC010048 Ranchi, Jharkhand, India
Humworld Solutions Private Limited U74900TN2012PTC085500 Chennai, Tamil Nadu, India
Rsg Software Services Private Limited U72900DL2009PTC189963 New Delhi, Delhi, India
Searchfit Ecommerce Solutions Private Limited U72300DL2007PTC165886 New Delhi, Delhi, India
Digindia Tradelink Private Limited U46101MH2010PTC207622 Kalyan, Maharashtra, India
Narmada Tech Solutions Private Limited U72502MP2017PTC044598 Indore, Madhya Pradesh, India
Non Stop Ventures Private Limited U74999TN2015PTC103137 Chennai, Tamil Nadu, India
Lavasa U72900MH2009PLC194613 Vikhroli West, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Clinicea before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Clinicea: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 80/100, margin trends, ownership structure and peer set for Clinicea - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Clinicea pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Clinicea - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Clinicea an active company?

Clinicea has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Clinicea financially healthy?

Clinicea has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Clinicea?

Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Clinicea?

Promoters hold a majority stake - exact percentages are in the full report. 4 active director(s) are on record.

Does Clinicea have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Clinicea up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Clinicea?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.